Skip to main content
Sona Nanotech Inc. logo

Sona Nanotech Inc. — Investor Relations & Filings

Ticker · SONA ISIN · CA83541C1059 CSE Professional, scientific and technical activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2021-03-31 Regulatory Filings
Country CA Canada
Listing CSE SONA

About Sona Nanotech Inc.

https://www.sonanano.com/

Sona Nanotech Inc. is a life sciences company specializing in the development and commercialization of proprietary, uniquely biocompatible gold nanorod (GNR) technology. The primary therapeutic focus is Targeted Hyperthermia Therapy (THT), a photothermal cancer treatment utilizing GNRs to deliver precision heat directly to solid tumors. THT is designed to reduce tumor burden and stimulate immunogenic cell death while minimizing harm to healthy tissue. Sona is advancing THT through clinical trials for solid cancers, including melanoma. Furthermore, the company manufactures and supplies its patented, CTAB-free gold nanoparticles (nanorods and nanospheres) for integration into advanced materials science and medical diagnostic applications, such as lateral flow assays.

Recent filings

Filing Released Lang Actions
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter of consent from a legal firm regarding a Final Base Shelf Prospectus dated March 31, 2021. It is addressed to multiple securities commissions and confirms the firm's consent to the use of their name in the Prospectus under 'Legal Matters and Interests of Experts.' The document does not contain financial data, report content, or detailed analysis but is a regulatory consent related to a financing document (the Prospectus). The document length is short (1563 characters), and it is a letter of consent rather than the Prospectus itself. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory documents and consents that do not fit other categories.
2021-03-31 English
Final short form prospectus – English.pdf
Capital/Financing Update Classification · 100% confidence The document is a 'Short Form Base Shelf Prospectus' for Sona Nanotech Inc., dated March 31, 2021. It discusses the offering of securities including common shares, debt securities, warrants, subscription receipts, and units, with detailed terms and conditions. The text includes legal disclaimers, regulatory references (such as Canadian securities legislation and National Instrument 44-102), and information about the plan of distribution and risk factors. This type of document is a formal offering prospectus used to raise capital and is not an announcement or summary of financial results, nor is it a regulatory filing or certification. It is a capital markets document related to financing activities. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length (15,000 characters) and content confirm it is a full prospectus, not a brief announcement or supplement.
2021-03-31 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from an independent auditor providing consent for the use of their audit report in a short form base shelf prospectus dated March 31, 2021. It references the auditor's report on financial statements for fiscal years ended October 31, 2020 and 2019. The letter states that the auditor has read the prospectus and consents to the use of their report but clarifies that this consent does not constitute an audit or review of the prospectus itself. The document is short (2205 characters) and serves as an auditor's consent letter related to a prospectus filing, not the audit report itself or the full prospectus. According to the Certification Rule and the Menu vs Meal Rule, such a consent letter is classified as a Regulatory Filing (RNS) rather than an Audit Report or Prospectus document.
2021-03-31 English
News release - English.pdf
Regulatory Filings
2021-03-23 English
Decision Document (Preliminary).pdf
Regulatory Filings Classification · 95% confidence The document is a receipt from the Nova Scotia Securities Commission for the Preliminary Short Form Base Shelf Prospectus of Sona Nanotech Inc. It is an official acknowledgment of filing rather than the prospectus itself or a detailed financial report. The document length is short (1123 characters) and it serves as a regulatory acknowledgment. Therefore, it fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not contain financial data or detailed report content.
2021-03-23 English
Preliminary short form prospectus – English.pdf
Capital/Financing Update Classification · 95% confidence The document is a decision from the Autorité des marchés financiers (AMF) regarding approval for an external placement of ordinary shares by La Compagnie Électrique Lion. It references regulatory articles and the approval of a placement (financing activity). The document is short (1486 characters) and is an official approval notice rather than a detailed financial report or presentation. It does not contain financial statements or detailed analysis, nor is it a report publication announcement. The content clearly relates to a capital raising or financing activity approval. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-03-23 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.